Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans

Kristina Busygina, Janina Jamasbi, Till Seiler, Hans Deckmyn, Christian Weber, Richard Brandl, Reinhard Lorenz, Wolfgang Siess

Blood (2018) 131 (24): 2605–2616.

https://doi.org/10.1182/blood-2017-09-808808

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

Venetoclax and obinutuzumab in chronic lymphocytic leukemia

Blood (2017) 129 (19): 2702–2705.

https://doi.org/10.1182/blood-2017-01-761973

Published: 2017

Includes: Supplemental data

Journal Articles

Low Incidence of Tumor Lysis Syndromes (TLS) and Infusion Related Reactions (IRR) in the CLL2-Bag Trial Evaluating a Sequential Treatment of Bendamustine (B), Obinutuzumab (GA101, G) and Venetoclax (ABT-199, A) in Patients with Chronic Lymphocytic Leukemia (CLL): Interim Safety Results of a Phase-II-Trial of the German CLL Study Group (GCLLSG)

Paula Cramer, MD, Julia von Tresckow, MD, Jasmin Bahlo, PhD, Sandra Robrecht, Anja Engelke, MD, Petra Langerbeins, MD, Anna-Maria Fink, MD, Hyatt Balke-Want, MD, Othman Al-Sawaf, MD, Till Seiler, MD, Ludwig Fischer von Weikersthal, MD, Holger Hebart, MD, Kirsten Fischer, MD, Clemens-Martin Wendtner, MD, Stephan Stilgenbauer, Barbara F. Eichhorst, MD, Michael Hallek

Blood (2016) 128 (22): 2044.

https://doi.org/10.1182/blood.V128.22.2044.2044

Published: 2016

Journal Articles

Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase III Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions

Blood (2015) 126 (23): 496.

https://doi.org/10.1182/blood.V126.23.496.496

Published: 2015

Journal Articles

Subcutaneous Alemtuzumab Combined with Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT In CLL with 17p- or Refractory to Fludarabine – Interim Analysis of the CLL2O Trial of the GCLLSG and FCGCLL/MW

Blood (2010) 116 (21): 920.

https://doi.org/10.1182/blood.V116.21.920.920

Published: 2010

Journal Articles

Identification and Characterization of Peptide Ligands for Stereotyped Subset and Non-Subset B-Cell Receptors of Patients with M- and U-CLL.

Manuela Woelfle, Till Seiler, Rosa Catera, Hartmut Dohner, Stephan Stilgenbauer, MD, Steven L Allen, Kanti R Rai, MD, Charles Chu, PhD, Nicholas Chiorazzi, MD

Blood (2009) 114 (22): 4369.

https://doi.org/10.1182/blood.V114.22.4369.4369

Published: 2009

Journal Articles

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells

Till Seiler, Manuela Woelfle, Sophia Yancopoulos, Rosa Catera, Wentian Li, Katerina Hatzi, Carol Moreno, Marcela Torres, Santanu Paul, Hartmut Dohner, Stephan Stilgenbauer, Matthew S. Kaufman, Jonathan E. Kolitz, Steven L. Allen, Kanti R. Rai, Charles C. Chu, Nicholas Chiorazzi

Blood (2009) 114 (17): 3615–3624.

https://doi.org/10.1182/blood-2009-01-197822

Published: 2009

Includes: Supplemental data

Journal Articles

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Catabolic Chemical Modifications

Rosa Catera, Gregg J. Silverman, Katerina Hatzi, Till Seiler, Sebastien Didier, Lu Zhang, MA, Maxime Hervé, Eric Meffre, David Graham Oscier, MD, Helen Vlassara, Yifang Chen, Steven L. Allen, Kanti R. Rai, MD, Charles C. Chu, PhD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3150.

https://doi.org/10.1182/blood.V112.11.3150.3150

Published: 2008

Journal Articles

Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro

Manuela Woelfle, Till Seiler, Rosa Catera, Hartmut Dohner, Stephan Stilgenbauer, MD, PhD, Steven L. Allen, Kanti Rai, Charles Chu, PhD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3151.

https://doi.org/10.1182/blood.V112.11.3151.3151

Published: 2008

Journal Articles

BCRs of Mutated and Unmutated CLL Bind Peptides with Distinct Sequence Features: Evidence from Phage Display Libraries.

Manuela Woelfle, MD, Till Seiler, MD, Rosa Catera, PhD, Hartmut Dohner, MD, Stephan Stilgenbauer, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Charles C. Chu, PhD, Nicholas Chiorazzi, MD

Blood (2007) 110 (11): 1118.

https://doi.org/10.1182/blood.V110.11.1118.1118

Published: 2007

Journal Articles

Binding of CLL B-Cell Receptors to Viable and Apoptotic Human Cells Offers Insight into the Role of Autoantigens in Leukemic Transformation.

Rosa Catera, PhD, Katerina Hatzi, BA, Till Seiler, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Charles C. Chu, PhD, Nicholas Chiorazzi, MD

Blood (2007) 110 (11): 741.

https://doi.org/10.1182/blood.V110.11.741.741

Published: 2007

Journal Articles

Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes

Dirk Kienle, Axel Benner, Alexander Kröber, Dirk Winkler, Daniel Mertens, Andreas Bühler, Till Seiler, Ulrich Jäger, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer

Blood (2006) 107 (5): 2090–2093.

https://doi.org/10.1182/blood-2005-04-1483

Published: 2006

Includes: Supplemental data

Journal Articles

Short Telomeres Are Associated with Genetic Instability and the Occurrence of High Risk Genomic Aberrations in Chronic Lymphocytic Leukemia.

Alexander Kröber, MD, Pawel Grabowski, MD, Andreas Bühler, Till Seiler, MD, Hartmut Döhner, MD, Richard Rosenquist, MD, Göran Roos, MD, Stephan Stilgenbauer, MD

Blood (2005) 106 (11): 1178.

https://doi.org/10.1182/blood.V106.11.1178.1178

Published: 2005

Journal Articles

ZAP-70 Expression, VH-Mutation Status, Genomic Aberrations and Prognosis in Chronic Lymphocytic Leukemia.

Alexander Kröber, Dirk Kienle, Dirk Winkler, Andreas Bühler, Till Seiler, Christine Schöpflin, Sabrina Kless, Claire Paulus, Hartmut Döhner, Stephan Stilgenbauer

Blood (2004) 104 (11): 1920.

https://doi.org/10.1182/blood.V104.11.1920.1920

Published: 2004

Journal Articles

V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia

Alexander Kröber, Till Seiler, Axel Benner, Lars Bullinger, Elsbeth Brückle, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer

Blood (2002) 100 (4): 1410–1416.

https://doi.org/10.1182/blood.V100.4.1410.h81602001410_1410_1416

Published: 2002

NARROW

Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans

Venetoclax and obinutuzumab in chronic lymphocytic leukemia

Subcutaneous Alemtuzumab Combined with Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT In CLL with 17p- or Refractory to Fludarabine – Interim Analysis of the CLL2O Trial of the GCLLSG and FCGCLL/MW

Identification and Characterization of Peptide Ligands for Stereotyped Subset and Non-Subset B-Cell Receptors of Patients with M- and U-CLL.

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Catabolic Chemical Modifications

Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro

BCRs of Mutated and Unmutated CLL Bind Peptides with Distinct Sequence Features: Evidence from Phage Display Libraries.

Binding of CLL B-Cell Receptors to Viable and Apoptotic Human Cells Offers Insight into the Role of Autoantigens in Leukemic Transformation.

Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes

Short Telomeres Are Associated with Genetic Instability and the Occurrence of High Risk Genomic Aberrations in Chronic Lymphocytic Leukemia.

ZAP-70 Expression, VH-Mutation Status, Genomic Aberrations and Prognosis in Chronic Lymphocytic Leukemia.

V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only